Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for patients with hormone receptor-positive metastatic breast cancer.

The findings of this study suggest a narrowing of racial and ethnic disparities in receipt of ERBB2 (formerly HER2 or HER2/neu)-targeted therapies over time among older Medicare beneficiaries with ...

After a career in contemporary dance, a shift to visual arts, and a move from Switzerland to New Zealand, artist Nela ...

Triple negative breast cancer is aggressive and hard to treat. It also disproportionately affects Black women. A University ...

Positive interim results from the Phase III DESTINY-Breast09 trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), ...

Breast cancer deaths among women ages 20-49 declined significantly between 2010 and 2020, according to a new study.

The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

On Feb. 7, AstraZeneca announced it received a Notice of Transfer to the Prosecutor and an Appraisal Opinion from the ...

Recent JCU research shows how nanoparticles can enhance breast cancer diagnosis and treatment. A medical student at James ...

In recent years, the treatment landscape of HR+/HER2−ve breast cancer has completely changed with the introduction of particularly active targeted drugs, from CDK4/6 inhibitors, mTOR inhibitors, and ...

A new commercial for AstraZeneca’s Truqap constructs a vision of the extra time that the AKT inhibitor can unlock for some ...